Eftilagimod Alpha (a Soluble LAG-3 Protein) Combined With Pembrolizumab in Second-Line Metastatic NSCLC Refractory to Anti–Programmed Cell Death Protein 1/Programmed Death-Ligand 1... by Krebs, Matthew G., MD, Forster, Martin, MD, PhD, Majem, Margarita, MD, PhD, Peguero, Julio, MD, Iams, Wade, MD, Clay, Tim, MD, Roxburgh, Patricia, MD, PhD, Doger, Bernard, MD, PhD, Bajaj, Pawan, MD, Barba, Andres, MD, Perera, Suvini, MS, Mueller, Christian, MS, Triebel, Frédéric, MD, PhD

Get full text